Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;51(5):541-8.
doi: 10.1002/ppul.23312. Epub 2015 Sep 14.

Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia

Lilliam Ambroggio  1   2   3 , Matthew Test  1 , Joshua P Metlay  4 , Thomas R Graf  5 , Mary Ann Blosky  6 , Maurizio Macaluso  2   3 , Samir S Shah  1   3   7
Affiliations

Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia

Lilliam Ambroggio et al. Pediatr Pulmonol. 2016 May.

Abstract

Objective: The objective was to evaluate the comparative effectiveness of beta-lactam monotherapy and beta- lactam/macrolide combination therapy in the outpatient management of children with community-acquired pneumonia (CAP).

Methods: This retrospective cohort study included children, ages 1-18 years, with CAP diagnosed between January 1, 2008 and January 31, 2010 during outpatient management in the Geisinger Health System. The primary exposure was receipt of beta-lactam monotherapy or beta-lactam/macrolide combination therapy. The primary outcome was treatment failure, defined as a follow-up visit within 14 days of diagnosis resulting in a change in antibiotic therapy. Logistic regression within a propensity score- restricted cohort was used to estimate the likelihood of treatment failure.

Results: Of 717 children in the analytical cohort, 570 (79.4%) received beta-lactam monotherapy and 147 (20.1%) received combination therapy. Of those who received combination therapy 58.2% of children were under 6 years of age. Treatment failure occurred in 55 (7.7%) children, including in 8.1% of monotherapy recipients, and 6.1% of combination therapy recipients. Treatment failure rates were highest in children 6-18 years receiving monotherapy (12.9%) and lowest in children 6-18 years receiving combination therapy (4.0%). Children 6-18 years of age who received combination therapy were less likely to fail treatment than those who received beta-lactam monotherapy (propensity-adjusted odds ratio, 0.51; 95% confidence interval, 0.28, 0.95).

Conclusion: Children 6-18 years of age who received beta- lactam/macrolide combination therapy for CAP in the outpatient setting had lower odds of treatment failure compared with those who received beta-lactam monotherapy.

Keywords: amoxicillin; child; comparative effectiveness research; pediatric; pneumonia; pneumonia bacterial.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

References

    1. Kronman MP, Hersh AL, Feng R, Huang YS, Lee GE, Shah SS. Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994–2007. Pediatrics 2011;127:411–418. - PMC - PubMed
    1. Esposito S Management of community-acquired pneumonia in infants and children older than 3 months. Clin Infect Dis 2012;54:884–885. - PubMed
    1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr., Moore MR, St Peter SD, Stockwell JA, Swanson JT, Pediatric Infectious Diseases S, the Infectious Diseases Society of A. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53:e25–e76. - PMC - PubMed
    1. Gould IM. BTS guidelines on CAP. Community acquired pneumonia. Thorax 2002;57:657. - PMC - PubMed
    1. Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, Knuf M, Lutsar I, Principi N, Rodrigues F, Sharland M, Spoulou V, Syrogiannopoulos GA, Usonis V, Vergison A, Schaad UB. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat?. Pediatr Infect Dis J 2012;31:e78–e85. - PubMed